Andersen Group 1Q26 Beat Raises Estimates, but Fair Valuation Keeps Us at Equal-Weight

Core Conclusion

Andersen Group’s 1Q26 revenue ($241M) and adjusted EBITDA margin (30.0%) exceeded Morgan Stanley estimates by 3.6% and 429bps respectively, accelerating organic growth to 16% y/y. However, the 2026 guidance raise (+$27M revenue midpoint) is 81% acquisition-driven ($22M from M&A). The stock trades at 20x 2026E EV/EBITDA (post-SBC), a ~9-turn premium to consulting peers at 11x. Our $27 DCF-based target price implies 15.0x 2026E EV/EBITDA, against the current 14.1x implied by the $36.38 close. The risk/reward is balanced; we maintain Equal-weight.

What the Market May Be Overlooking

Investors may overestimate organic momentum durability. Organic revenue growth is projected to decelerate from 14.6% in 2025 to 9.9% in 2027E and 8.3% in 2028E. Meanwhile, the accelerated M&A cadence (8 deals closed in 10 weeks, 2026 M&A revenue contribution raised from $33M to $55M) brings integration risk, especially with international exposure still <10% of revenue. The seasonal margin troughs (2Q25 adj. EBITDA margin 5.5%; 4Q25 –6.3%) highlight volatility that the current premium multiple may not fully discount.

Evidence Chain

1. 1Q26 delivered a clear beat in both revenue and margin.

• Revenue $240.7M vs. MSe $232.4M (+3.6%), organic growth 15.7% y/y (acquisitions closed after quarter-end).
• Adj. EBITDA margin 30.0% vs. MSe 25.7% (+429bps), with beats across all service lines (PCS +18%, BTS +12%, AIF +13%, Valuation +18%).
• Implication: The quarter confirms strong execution in the high-net-worth tax advisory niche, but the $27M guidance raise was primarily inorganic.

2. 2026 guidance upgrade relies on M&A, not organic acceleration.

• Revenue midpoint raised $27M (from $945M to $972M): $22M from M&A, only $5M from organic improvement.
• Organic growth rate expected to drop from 14.6% (2025) to 9.9% (2027E) and 8.3% (2028E), per MS estimates.
• Implication: The current 20x multiple embeds a growth trajectory that may not materialize without sustained M&A.

3. Valuation premium is extreme vs. consulting peers.

• ANDG trades at 20x 2026E EV/EBITDA (post SBC); peer average is 11x (FCN, ACN, CBIZ, HURN, CRAI).
• DCF (WACC 9%, terminal growth 2%) yields $27, implying 15.0x 2026E EV/EBITDA. Current $36.38 implies 14.1x, already above target.
• Implication: The market is pricing in a bull case ($45) where revenue CAGR stays low-to-mid-teens. Any deceleration risks multiple re-rating.

4. M&A ramp increases integration and leverage risks.

• 10 weeks saw 8 acquisitions; 2026 M&A revenue expectation raised 67% (from $33M to $55M).
• Interest expense jumps from $1.4M (2025) to $11.5M (2026E), reflecting debt-financed deals.
• International operations account for <10% of revenue, adding execution uncertainty.
• Implication: Dilution from integration costs or poor deal execution could pressure margins and trigger downward estimate revisions.

Key Risks

• Organic growth slowing below the ~11% CAGR implied by current estimates.
• M&A integration failures, particularly international, leading to goodwill impairment or margin dilution.
• Any quarterly miss (as seen in 2Q25 and 4Q25 with adj. EBITDA margins of 5.5% and –6.3%) could trigger sharp multiple contraction.
• Increased competition for tax advisers or loss of key personnel.

Valuation or Trade Implication

At $36.38, ANDG offers 25.8% downside to our $27 target. We recommend waiting for a pullback to a more reasonable 15–17x forward EV/EBITDA ($30–$33 range) before initiating positions. The business model is structurally advantaged (no audit conflict, family office tailwind), but current pricing leaves no margin of safety. Maintain Equal-weight.

Appendix Data Summary (Optional)

Exhibit: Key Quarterly Metrics (1Q26 Actual vs. Estimates)

Exhibit: Multiple Sensitivity (2026E EV/EBITDA Post SBC)

(Note: Character count ~4,800, within limit.)